Neonatal Diagnostics Company InfanDx AG Appoints Dr. Gunter Weiss as COO
Cologne, Germany, August 4, 2021 InfanDx AG (Cologne, Germany), a privately held diagnostics company focusing on the development and commercialization of novel diagnostic solutions for newborns, today announced the appointment of Dr. Gunter Weiss as Chief Operating Officer (COO).
- Cologne, Germany, August 4, 2021 InfanDx AG (Cologne, Germany), a privately held diagnostics company focusing on the development and commercialization of novel diagnostic solutions for newborns, today announced the appointment of Dr. Gunter Weiss as Chief Operating Officer (COO).
- Dr. Weiss brings to InfanDx more than 15 years of experience in biomarker and IVD development for the European, US and Chinese market.
- Dr. Weiss joins InfanDx from a position as Senior Vice President Product Development at Epigenomics AG (Berlin, Germany), where he headed the development of cancer-related diagnostic IVD products.
- InfanDx AG is a privately held company focusing on the development and commercialization of novel diagnostic solutions for acute and critical care conditions in newborns.